Codiak BioSciences Inc. (CDAK)

NASDAQ: CDAK · Real-Time Price · USD

0.06

0.00 (5.26%)

At close: Apr 04, 2023, 8:00 PM

Codiak BioSciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q4 2019
Period Ending	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Dec 31, 2019
Cash & Equivalents	51.76M	41.78M	56.49M	76.94M	98.58M	113.68M	130.27M	88.92M	48.34M	50.95M	10.32M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	73.06M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	31.67M	33.84M	36.06M	36.06M	4.17M	4.17M	4.17M	4.17M	4.22M	4.25M	4.22M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.91M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	9.47M	14.22M	13.42M	13.23M	5.33M	5.64M	4.41M	4.84M	4.02M	1.62M	4.83M
Total Current Assets	61.23M	56.01M	69.91M	90.17M	103.91M	119.32M	134.68M	93.76M	52.36M	52.57M	94.12M
Property-Plant & Equipment	41.49M	42.86M	44.09M	45.44M	50.64M	51.78M	52.65M	53.41M	53.77M	53.51M	17.63M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	73.16M	76.7M	80.16M	81.5M	54.81M	55.95M	56.82M	57.58M	57.99M	57.76M	21.84M
Total Assets	134.4M	132.71M	150.07M	171.67M	158.72M	175.27M	191.5M	151.34M	110.35M	110.32M	115.96M
Account Payables	1.96M	1.13M	1.52M	1.84M	2M	1.78M	2.16M	2.02M	2.49M	2.11M	2.38M
Deferred Revenue	1.36M	292K	442K	12.96M	9.35M	9.12M	4.34M	5.28M	6.27M	7.74M	742K
Short-Term Debt	3.01M	2.89M	2.77M	2.66M	2.44M	2.33M	2.23M	1.48M	1.78M	359K	n/a
Other Current Liabilities	8.13M	7.7M	6.81M	9.7M	9.31M	7.69M	6.8M	8.87M	23.86M	8.48M	16.63M
Total Current Liabilities	14.46M	12.01M	11.54M	27.16M	23.1M	20.92M	15.54M	17.65M	34.39M	18.69M	19.75M
Long-Term Debt	32.57M	58.96M	59.65M	34.88M	60.02M	60.54M	25.09M	24.96M	24.82M	9.71M	9.57M
Other Long-Term Liabilities	31.12M	n/a	n/a	25.43M	207K	207K	36.14M	36.75M	37.1M	37.64M	9.81M
Total Long-Term Liabilities	81.01M	76.3M	90.15M	91M	101.62M	102.49M	107.24M	119.12M	120M	104.89M	74.26M
Total Liabilities	95.47M	88.31M	101.69M	118.17M	124.72M	123.41M	122.78M	136.77M	154.39M	123.58M	94.01M
Total Debt	61.28M	61.85M	62.42M	37.55M	62.45M	62.87M	27.32M	26.44M	26.6M	10.06M	82.64M
Common Stock	4K	2K	2K	2K	2K	2K	2K	2K	n/a	1K	n/a
Retained Earnings	-359.33M	-340.05M	-333.27M	-325.25M	-341.91M	-320.21M	-298.4M	-288.09M	-270.13M	-212.04M	-192.88M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	43K
Shareholders Equity	38.93M	44.4M	48.38M	53.51M	34.01M	51.86M	68.72M	14.57M	-44.04M	-13.26M	21.95M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	73.06M